Vaginal progesterone for prevention of preterm birth in asymptomatic high-risk women with a normal cervical length: a systematic review and meta-analysis protocol
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2046-4053
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Vaginal progesterone for prevention of preterm birth in asymptomatic high-risk women with a normal cervical length: a systematic review and meta-analysis protocol ; volume:10 ; number:1 ; day:21 ; month:5 ; year:2021 ; pages:1-6 ; date:12.2021
Systematic Reviews ; 10, Heft 1 (21.5.2021), 1-6, 12.2021
- Creator
-
Williams, Kimberley P.
McAuliffe, Liam
Diacci, Rosanna
Aubin, Anne-Marie
Issah, Ashad
Wang, Carol
Phung, Jason
Pennell, Craig E.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13643-021-01702-9
- URN
-
urn:nbn:de:101:1-2021091907510846132209
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Williams, Kimberley P.
- McAuliffe, Liam
- Diacci, Rosanna
- Aubin, Anne-Marie
- Issah, Ashad
- Wang, Carol
- Phung, Jason
- Pennell, Craig E.
- SpringerLink (Online service)
Other Objects (12)
The interaction between vaginal microbiota, cervical length, and vaginal progesterone treatment for preterm birth risk
Does vaginal bacterial colonization contribute to preterm birth in women with asymptomatic shortened cervix?
Vaginal progesterone to reduce preterm birth among HIV-infected pregnant women in Zambia: a feasibility study protocol
The vaginal microbiome and preterm birth
Patients’ administration preferences: progesterone vaginal insert (Endometrin®) compared to intramuscular progesterone for Luteal phase support
Treatment of asymptomatic vaginal candidiasis in pregnancy to prevent preterm birth: an open-label pilot randomized controlled trial
Vaginal progesterone for the prevention of preterm birth: who can benefit and who cannot? Evidence-based recommendations for clinical use
Prevention of Preterm Birth by Cervical Pessary Combined with Vaginal Progesterone: a Systematic Review and Meta-analysis with Trial Sequential Analysis
Rescue Adjuvant Vaginal Progesterone May Improve Outcomes in Cervical Cerclage Failure
The vaginal microbial signatures of preterm birth woman
Early blood glucose screening in asymptomatic high-risk neonates
Clinical Application of Progesterone for the Prevention of Preterm Birth, 2016
The interaction between vaginal microbiota, cervical length, and vaginal progesterone treatment for preterm birth risk
Does vaginal bacterial colonization contribute to preterm birth in women with asymptomatic shortened cervix?
Vaginal progesterone to reduce preterm birth among HIV-infected pregnant women in Zambia: a feasibility study protocol
The vaginal microbiome and preterm birth
Patients’ administration preferences: progesterone vaginal insert (Endometrin®) compared to intramuscular progesterone for Luteal phase support
Treatment of asymptomatic vaginal candidiasis in pregnancy to prevent preterm birth: an open-label pilot randomized controlled trial
Vaginal progesterone for the prevention of preterm birth: who can benefit and who cannot? Evidence-based recommendations for clinical use
Prevention of Preterm Birth by Cervical Pessary Combined with Vaginal Progesterone: a Systematic Review and Meta-analysis with Trial Sequential Analysis
Rescue Adjuvant Vaginal Progesterone May Improve Outcomes in Cervical Cerclage Failure
The vaginal microbial signatures of preterm birth woman
Early blood glucose screening in asymptomatic high-risk neonates
Clinical Application of Progesterone for the Prevention of Preterm Birth, 2016
The interaction between vaginal microbiota, cervical length, and vaginal progesterone treatment for preterm birth risk
Does vaginal bacterial colonization contribute to preterm birth in women with asymptomatic shortened cervix?
Vaginal progesterone to reduce preterm birth among HIV-infected pregnant women in Zambia: a feasibility study protocol
The vaginal microbiome and preterm birth
Patients’ administration preferences: progesterone vaginal insert (Endometrin®) compared to intramuscular progesterone for Luteal phase support
Treatment of asymptomatic vaginal candidiasis in pregnancy to prevent preterm birth: an open-label pilot randomized controlled trial
Vaginal progesterone for the prevention of preterm birth: who can benefit and who cannot? Evidence-based recommendations for clinical use
Prevention of Preterm Birth by Cervical Pessary Combined with Vaginal Progesterone: a Systematic Review and Meta-analysis with Trial Sequential Analysis
Rescue Adjuvant Vaginal Progesterone May Improve Outcomes in Cervical Cerclage Failure
The vaginal microbial signatures of preterm birth woman
Early blood glucose screening in asymptomatic high-risk neonates